Jpmorgan Chase & CO Surmodics Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Surmodics Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 42,470 shares of SRDX stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,470
Previous 14,510
192.69%
Holding current value
$1.62 Million
Previous $610,000
169.84%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SRDX
# of Institutions
126Shares Held
12MCall Options Held
1.4KPut Options Held
8.6K-
Black Rock Inc. New York, NY1.17MShares$44.6 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.04MShares$39.6 Million0.01% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA989KShares$37.7 Million14.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$30.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY753KShares$28.7 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $533M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...